Instil Bio (TIL) Assets Average (2021 - 2026)
Instil Bio (TIL) posted quarterly Assets Average of $202.0 million for Q1 2026, down 19.37% year-over-year from $250.5 million in Q1 2025, and down 2.73% quarter-over-quarter from $207.6 million in Q4 2025.
Instil Bio (TIL) Assets Average (2021 - 2026) Analysis & Trends
Instil Bio's Assets Average history runs 6 years deep, the most recent figure standing at $202.0 million for Q1 2026.
- In Q1 2026, Assets Average fell 19.37% year-over-year to $202.0 million; the TTM figure through Mar 2026 stood at $202.0 million (down 19.37% YoY), while the FY2025 annual figure was $233.5 million, down 20.72% from the prior year.
- Assets Average for Q1 2026 stood at $202.0 million, down from $207.6 million in the prior quarter.
- The five-year high for Assets Average was $587.5 million in Q1 2022, with the low at $202.0 million in Q1 2026.
- The 5-year median for Assets Average is $316.0 million (2024), against an average of $357.4 million.
- The sharpest annual moves came in 2022 and 2023: Assets Average rose 15.74% in 2022, then slumped 34.39% in 2023.
- Instil Bio's Assets Average stood at $507.4 million in 2022, then plunged by 34.39% to $333.0 million in 2023, then retreated by 19.49% to $268.1 million in 2024, then fell by 22.54% to $207.6 million in 2025, then decreased by 2.73% to $202.0 million in 2026.
- Business Quant data shows TIL's Assets Average at $202.0 million in Q1 2026, $207.6 million in Q4 2025, and $221.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Instil Bio | 51.34 Mn | 51.34 Mn | - | 199.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 199.07 Mn |
| Mar 31, 2026 | 201.98 Mn |
| Dec 31, 2025 | 207.65 Mn |
| Sep 30, 2025 | 221.38 Mn |
| Jun 30, 2025 | 234.22 Mn |
| Mar 31, 2025 | 250.51 Mn |
| Dec 31, 2024 | 268.06 Mn |
| Sep 30, 2024 | 283.44 Mn |
| Jun 30, 2024 | 300.31 Mn |
| Mar 31, 2024 | 315.97 Mn |
| Dec 31, 2023 | 332.95 Mn |
| Sep 30, 2023 | 374.29 Mn |
| Jun 30, 2023 | 417.74 Mn |
| Mar 31, 2023 | 454.65 Mn |
| Dec 31, 2022 | 507.43 Mn |
| Sep 30, 2022 | 550.64 Mn |
| Jun 30, 2022 | 566.74 Mn |
| Mar 31, 2022 | 587.46 Mn |
| Dec 31, 2021 | 628.69 Mn |
| Sep 30, 2021 | 660.03 Mn |